Loading...
Pneumatocele during sorafenib therapy: first report of an unusual complication
Sorafenib is a multi-kinase inhibitor and a vascular endothelial growth factor (VEGF) inhibitor approved to treat patients with advanced hepatocellular carcinoma, renal cell carcinoma and differentiated thyroid carcinoma. Its most common side effects are asthenia/fatigue, skin toxicity, diarrhea and...
Na minha lista:
| Udgivet i: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Impact Journals LLC
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5814241/ https://ncbi.nlm.nih.gov/pubmed/29464101 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23599 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|